“China Patent Award” is an award in China specifically granted to inventions and creations that have been granted patent rights, recognized by the World Intellectual Property Organization (WIPO) of the United Nations and having a certain influence internationally. The selection criteria include multiple dimensions such as patent quality, advanced technical level, application and protection measures and effectiveness during market transformation, social benefits, and economic benefits. The level of winning patents not only represents the high standard of national independent scientific and technological innovation but also signifies that corporate technology patents have gone global and gained international industry recognition. Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. winning this award for the first time is a high affirmation of the company’s R&D capabilities and independent innovation research strength.
Breaking international monopoly, leading the industry with scientific research innovation capability
It is reported that the key excipient for intravenous fat emulsion internationally—injectable egg yolk phosphatidylcholine—due to its complex extraction process and technology, is mastered by only a few foreign companies such as Germany, which have realized its industrial production. However, Baiyunshan Hanfang adheres to the R&D philosophy of “quality, safety, efficiency, and stability,” overcomes numerous key technical difficulties, successfully achieves the industrialization and domestic production of injectable egg yolk phosphatidylcholine—a rare achievement in China—breaks the monopoly, and accelerates the development of China’s fat emulsion field.
The award-winning project of Baiyunshan Hanfang this time further develops a high-purity injectable egg yolk phosphatidylcholine product, once again demonstrating Baiyunshan Hanfang’s high-level independent scientific and technological innovation strength.
Technology-based, innovation-focused, setting an industry quality benchmark
Baiyunshan Hanfang’s winning of the China Patent Excellence Award this time is by no means accidental; it stems from long-term persistence and effort.
Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd., affiliated with Guangzhou Pharmaceutical Group, is a high-tech enterprise specializing in the production of health supplements, special medical purpose formula foods, specialty APIs, high-end pharmaceutical lipid raw and auxiliary materials, natural medicines and preparations, a demonstration base for the industrialization of high-tech traditional Chinese medicine extraction, separation, and purification, and moreover, it is the “National Engineering Research Center for the Modernization of Traditional Chinese Medicine Extraction, Separation, and Purification Process” approved for construction by relevant departments.
Committed to becoming a pioneer enterprise in health nutrition technology and a supplier of specialty raw and auxiliary materials
Throughout the years, Baiyunshan Hanfang has adhered to the development concept of “professionalism, technology, and peace of mind,” fully leveraging the leading scientific research advantages of the National Engineering Research Center, achieving remarkable accomplishments in technological innovation, intellectual property, and other fields. It has not only undertaken more than 80 science and technology projects at national, provincial, and municipal levels, obtained 54 authorized invention patents, published more than 200 academic papers and one academic monograph, but also won multiple honorary titles such as National High-Tech Industrialization Demonstration Project, Provincial and Municipal Key Laboratory of Pharmaceutical Lipids, Provincial Independent Innovation Demonstration Enterprise, and Provincial Enterprise Technology Center. Moreover, its related products have obtained EU CEP certification and it has also presided over the formulation of the international business standard for Ganoderma spore oil, setting an industry quality benchmark.
Guangzhou Pharmaceutical Ganoderma Spore Oil Wins Nine Invention Patents
In Baiyunshan Hanfang’s many years of scientific and technological innovation and R&D, Guangzhou Pharmaceutical Ganoderma Spore Oil is the core product through which Baiyunshan Hanfang inherits the thousand-year-old Ganoderma culture, combines modern scientific and technological innovation with traditional Chinese medicine, and meticulously crafts it. Made from high-quality Ganoderma spore powder as raw material, using patented technology to efficiently break cell walls and highly concentrate through multiple extractions, it yields Ganoderma spore essence nutrition. Its core functional components are highly concentrated, rich in active ingredients such as Ganoderma ergosterol, which can enhance immunity.
Guangzhou Pharmaceutical Ganoderma Spore Oil has obtained nine national invention patents (ZL200410051412.4, etc.), and in July 2018, Baiyunshan Hanfang, with its strong scientific and technological strength, presided over the formulation of the international business standard for Ganoderma spore oil, leading the industry’s quality standards.
